Drug Type Gut microbiota |
Synonyms LS-LBP 01, LS-LBP-001 |
Target- |
Action modulators |
Mechanism Gastrointestinal microbiome modulators |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePhase 1/2 |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Crohn Disease | Phase 2 | China | - |





